Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Breast cancer
  • (-) ≠ Daly, M.B.
  • (-) = Bochove, A. van

Search results

  • RSS Feed
(1 - 3 of 3)
Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)
Rossum, A.G.J. van; Kok, M.; Werkhoven, E. van; Opdam, M.; Mandjes, I.A.M.; Leeuwen-Stok, A.E. van; ... ; MATADOR Trialists' Grp 2018
Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)
Article / Letter to editor
open access
Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)
Charehbili, A.; Hamdy, N.A.T.; Smit, V.T.H.B.M.; Kessels, L.; Bochove, A. van; Laarhoven, H.W. van; ... ; Dutch Breast Canc Res Grp BOOG 2016
Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)
Article / Letter to editor
metadata only
Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
Groot, S. de; Janssen, L.G.M.; Charehbili, A.; Dijkgraaf, E.M.; Smit, V.T.H.B.M.; Kessels, L.W.; ... ; Kroep, J.R. 2015
Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
Article / Letter to editor
metadata only